Stryker Corporation $SYK Position Reduced by Citizens Financial Group Inc. RI

Key Points

• Citizens Financial Group reduced its Stryker position by 26.8% in the third quarter, selling 17,986 shares and retaining 49,089 shares valued at $13.5 million. Institutional investors collectively own 77.09% of SYK.
• Stryker insiders sold 351,267 shares worth approximately $118.2 million over the past three months, including a 300,000-share sale by director Ronda Stryker.
• Analysts maintain a “Moderate Buy” consensus with an average price target of $369, despite several recent target-price cuts. Stryker also exceeded quarterly EPS estimates, with revenue rising 9.4% year over year, and declared a quarterly dividend of $0.88 per share.

Citizens Financial Group Inc. RI decreased its position in Stryker Corporation (NYSE:SYK - Free Report) by 26.8% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 49,089 shares of the medical technology company's stock after selling 17,986 shares during the quarter. Citizens Financial Group Inc. RI's holdings in Stryker were worth $13,519,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of SYK. Mitchell Mcleod Pugh & Williams Inc. grew its stake in shares of Stryker by 1.2% during the 1st quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 2,678 shares of the medical technology company's stock valued at $880,000 after purchasing an additional 31 shares during the period. Community Bank & Trust Waco Texas lifted its stake in shares of Stryker by 2.3% in the 2nd quarter. Community Bank & Trust Waco Texas now owns 1,395 shares of the medical technology company's stock worth $439,000 after purchasing an additional 31 shares during the period. Cornerstone Financial Management LLC lifted its stake in shares of Stryker by 66.0% in the 2nd quarter. Cornerstone Financial Management LLC now owns 78 shares of the medical technology company's stock worth $25,000 after purchasing an additional 31 shares during the period. NWF Advisory Services Inc. lifted its stake in shares of Stryker by 2.3% in the 2nd quarter. NWF Advisory Services Inc. now owns 1,472 shares of the medical technology company's stock worth $463,000 after purchasing an additional 33 shares during the period. Finally, Harold Davidson & Associates Inc. boosted its holdings in shares of Stryker by 0.4% in the first quarter. Harold Davidson & Associates Inc. now owns 8,668 shares of the medical technology company's stock worth $2,848,000 after buying an additional 34 shares during the last quarter. Institutional investors own 77.09% of the company's stock.

Insiders Place Their Bets

In other news, Director Ronda Stryker sold 300,000 shares of the stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $335.90, for a total value of $100,770,000.00. Following the completion of the sale, the director directly owned 2,301,375 shares of the company's stock, valued at $773,031,862.50. This represents a 11.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Dylan Crotty sold 441 shares of the firm's stock in a transaction on Friday, August 21st. The shares were sold at an average price of $328.61, for a total transaction of $144,917.01. Following the sale, the insider owned 6,102 shares in the company, valued at $2,005,178.22. The trade was a 6.74% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 351,267 shares of company stock worth $118,197,701 over the last three months. 4.60% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

SYK has been the subject of several recent research reports. Argus set a $370.00 target price on shares of Stryker in a research report on Thursday, July 9th. Canaccord Genuity Group reduced their target price on shares of Stryker from $400.00 to $385.00 and set a "buy" rating for the company in a report on Friday, September 18th. Truist Financial decreased their price target on shares of Stryker from $340.00 to $310.00 and set a "hold" rating on the stock in a research report on Tuesday, October 6th. Wells Fargo & Company dropped their price target on shares of Stryker from $418.00 to $348.00 and set an "overweight" rating on the stock in a research note on Wednesday, September 9th. Finally, TD Cowen cut their price objective on shares of Stryker from $355.00 to $298.00 and set a "hold" rating for the company in a research report on Tuesday, September 22nd. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $369.00.

Stryker Stock Up 0.2%

NYSE SYK opened at $307.65 on Friday. The stock's 50-day moving average price is $295.23 and its 200-day moving average price is $311.93. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59. Stryker Corporation has a 52 week low of $267.00 and a 52 week high of $389.33. The company has a market capitalization of $118.01 billion, a P/E ratio of 31.88, a price-to-earnings-growth ratio of 1.98 and a beta of 0.78.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.49 by $0.20. The company had revenue of $6.59 billion during the quarter, compared to the consensus estimate of $6.58 billion. Stryker had a return on equity of 23.63% and a net margin of 14.43%. The firm's revenue was up 9.4% on a year-over-year basis. During the same period in the previous year, the company posted $3.13 EPS. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, equities research analysts predict that Stryker Corporation will post 14.93 earnings per share for the current year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Wednesday, September 30th. Stryker's dividend payout ratio is presently 36.48%.

Stryker Profile

Stryker Corporation NYSE: SYK is a global medical technology company that develops and manufactures products used by healthcare providers in hospitals, surgical centers and other clinical settings. Its offerings are designed to support orthopaedic procedures, surgery, emergency care, neurovascular treatment and patient handling.

The company's product portfolio includes orthopaedic implants and instruments, products for trauma and spine procedures, surgical equipment, endoscopy systems, patient beds and stretchers, emergency medical equipment, and neurovascular devices used in the treatment of conditions such as stroke.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.